Caerus Investment Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$372K Sell
774
-1,523
-66% -$780K 0.15% 134
2025
Q4
$1.29M Buy
2,297
+720
+46% +$409K 0.42% 44
2025
Q3
$811K Buy
+1,577
New +$689K 0.33% 53

Other funds holding MEDP

Caerus Investment Advisors's MEDP Position: Q1 2026 in Review

Caerus Investment Advisors reduced its Medpace (MEDP) stake by 66% in Q1 2026, selling an estimated $780K and leaving 774 shares worth $372K. The position accounts for 0.15% of the portfolio, ranked #134.

Caerus Investment Advisors first reported a position in MEDP in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.29M in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Caerus Investment Advisors held 774 shares of Medpace worth $372K as of Q1 2026.
  • Caerus Investment Advisors sold 1,523 Medpace shares in Q1 2026, an estimated $780K.
  • Medpace made up 0.15% of Caerus Investment Advisors's portfolio in Q1 2026, its #134 holding.
  • Caerus Investment Advisors first reported a position in Medpace in Q3 2025 and has held it in 3 quarters since.
  • Caerus Investment Advisors's Medpace position peaked at $1.29M in Q4 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Caerus Investment Advisors's 13F filing for Q1 2026, filed 1 Jun 2026.